| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |